A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer
Clinical trial NCT01246960 · COMPLETED
Trial details
- NCT number
- NCT01246960
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2013-09-01
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.